These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25189396)

  • 1. Role of nitric oxide in pathophysiology and treatment of pulmonary hypertension.
    Kruzliak P; Maruyama J; Maruyama K
    Vitam Horm; 2014; 96():407-24. PubMed ID: 25189396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds.
    Hagan G; Pepke-Zaba J
    Expert Rev Respir Med; 2011 Apr; 5(2):163-71. PubMed ID: 21510727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Pulmonary Endothelial Hemoglobin α Improves Nitric Oxide Signaling and Reverses Pulmonary Artery Endothelial Dysfunction.
    Alvarez RA; Miller MP; Hahn SA; Galley JC; Bauer E; Bachman T; Hu J; Sembrat J; Goncharov D; Mora AL; Rojas M; Goncharova E; Straub AC
    Am J Respir Cell Mol Biol; 2017 Dec; 57(6):733-744. PubMed ID: 28800253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension.
    Gkaliagkousi E; Douma S; Zamboulis C; Ferro A
    J Hypertens; 2009 Dec; 27(12):2310-20. PubMed ID: 19838132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension, pulmonary blood vessels and vasoactive drugs.
    Wanstall JC
    Proc West Pharmacol Soc; 1997; 40():137-40. PubMed ID: 9436235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress.
    Jerkic M; Kabir MG; Davies A; Yu LX; McIntyre BA; Husain NW; Enomoto M; Sotov V; Husain M; Henkelman M; Belik J; Letarte M
    Cardiovasc Res; 2011 Dec; 92(3):375-84. PubMed ID: 21859819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension.
    Hampl V; Herget J
    Physiol Rev; 2000 Oct; 80(4):1337-72. PubMed ID: 11015616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in the pulmonary vascular bed.
    Chen YF; Oparil S
    Am J Med Sci; 2000 Oct; 320(4):223-32. PubMed ID: 11061346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin adds to the protective effect of L-arginine in monocrotaline-induced pulmonary hypertension in rats: favorable modulation of oxidative stress, inflammation and nitric oxide.
    Ahmed LA; Obaid AA; Zaki HF; Agha AM
    Eur J Pharm Sci; 2014 Oct; 62():161-70. PubMed ID: 24878387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.
    Hsu LL; Champion HC; Campbell-Lee SA; Bivalacqua TJ; Manci EA; Diwan BA; Schimel DM; Cochard AE; Wang X; Schechter AN; Noguchi CT; Gladwin MT
    Blood; 2007 Apr; 109(7):3088-98. PubMed ID: 17158223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of nitric oxide in the pathogenesis of pulmonary hypertension in broilers: a synopsis.
    Tan X; Hu SH; Wang XL
    Avian Pathol; 2007 Aug; 36(4):261-7. PubMed ID: 17620170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders.
    Gielis JF; Lin JY; Wingler K; Van Schil PE; Schmidt HH; Moens AL
    Free Radic Biol Med; 2011 Apr; 50(7):765-76. PubMed ID: 21172428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative and nitrosative stress in pediatric pulmonary hypertension: roles of endothelin-1 and nitric oxide.
    Black SM; Fineman JR
    Vascul Pharmacol; 2006 Nov; 45(5):308-16. PubMed ID: 17049313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension.
    Day RW
    Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats.
    Ou ZJ; Wei W; Huang DD; Luo W; Luo D; Wang ZP; Zhang X; Ou JS
    Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1131-9. PubMed ID: 20215577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats.
    Bi LQ; Zhu R; Kong H; Wu SL; Li N; Zuo XR; Zhou SM; Kou JP; Yu BY; Wang H; Xie WP
    Int Immunopharmacol; 2013 May; 16(1):7-16. PubMed ID: 23538027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and drug therapy of pulmonary hypertension at high altitude.
    Scherrer U; Allemann Y; Rexhaj E; Rimoldi SF; Sartori C
    High Alt Med Biol; 2013 Jun; 14(2):126-33. PubMed ID: 23795732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension: NO therapy?
    Adnot S; Raffestin B
    Thorax; 1996 Jul; 51(7):762-4. PubMed ID: 8882087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.